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Abstract
The objectives of this study were to determine the efficacy of metabolites of a Streptomyces strain AS1 on (a) spore germination,
(b) mycelial growth, (c) control of mycotoxins produced by Penicillium verrucosum (ochratoxin A, OTA), Fusarium
verticillioides (fumonisins, FUMs) and Aspergillus fumigatus (gliotoxin) and (d) identify the predominant metabolites involved
in control. Initial screening showed that the StreptomycesAS1 strain was able to inhibit the mycelial growth of the three species at
a distance, due to the release of secondary metabolites. A macroscopic screening system showed that the overall Index of
Dominance against all three toxigenic fungi was inhibition at a distance. Subsequent studies showed that the metabolite mixture
from the Streptomyces AS1 strain was very effective at inhibiting conidial germination of P. verrucosum, but less so against
conidia of A. fumigatus and F. verticillioides. The efficacy was confirmed in studies on a conducive semi-solid YES medium in
BioScreen C assays. Using the BioScreen C and the criteria of Time to Detection (TTD) at an OD = 0.1 showed good efficacy
against P. verrucosumwhen treated with the StreptomycesAS1 extract at 0.95 and 0.99 water activity (aw) when compared to the
other two species tested, indicating good efficacy. The effective dose for 50% control of growth (ED50) at 0.95 and 0.99 aw were
approx. 0.005 ng/ml and 0.15 μg/ml, respectively, with the minimum inhibitory concentration (MIC) at both aw levels requiring
> 40 μg/ml. In addition, OTA production was completely inhibited by 2.5 μg/ml AS1 extract at both aw levels in the in vitro
assays. Ten metabolites were identified with four of these being predominant in concentrations > 2 μg/g dry weight biomass.
These were identified as valinomycin, cyclo(L-Pro-L-Tyr), cyclo(L-Pro-L-Val) and brevianamide F.
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Introduction
There has been interest in the utilization of actively growing
natural microorganisms for the competitive exclusion of
toxigenic fungal species or by using their naturally produced
metabolites for inhibiting the germination and growth of these
pathogens that cause diseases of humans and contaminate
food and feed (Dogi et al. 2013; Faheem et al. 2015; Guo
et al. 2011). A key driver is the strict legislative limits, which
exist in many countries for mycotoxins in a range of raw and
processed staple commodities. Thus, minimization strategies
are actively being sought to reduce potential exposure to spoil-
age and toxigenic moulds in food and feed chains. There is
thus interest in the identification of natural compounds that
may control or reduce mycotoxigenic mould colonization and
toxin contamination of staple commodities.
Food and feeds such as cereals, nuts and spices are com-
monly contaminated with mycotoxigenic fungi and myco-
toxins that are a serious problem faced by many countries
(Lee and Ryu 2017). This causes significant losses to producer
countries when their exports are rejected because they do not
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meet the legislative limits, especially in Europe. The Rapid
Alert System for Food and Feed shows that up to 30% of
commodities imported into the EU are rejected because of
mycotoxin contamination (RASFF 2018). Species from the
genera Penicillium, Fusarium and Aspergillus are of greatest
concern in terms of mycotoxin contamination of food and
feed. A survey conducted in 2014 revealed that more than half
of the worlds’ regions were severely affected by mycotoxins
including fumonisins (FUMs), deoxynivalenol (DON) and
zearalenone (ZON) from Fusarium species which had in-
creased when compared to 2013 (Kovalsky 2015).
Moreover, the maximum and average ochratoxin A (OTA)
concentration in samples from Europe in 2017 was the highest
when compared to other regions (Biomin 2018). In a 4-year
survey by Limay-Rios et al. (2017) of stored wheat in Canada,
Penicillium verrucosum was commonly isolated, as well as
contamination with OTA, ochratoxin B (OTB) and citrinin.
Aspergillus fumigatus is an opportunistic fungal species,
responsible for aspergillosis due to lung infection.
Resistance to azoles has resulted in a number of virulent
strains which have become difficult to control (Chowdhary
et al. 2013), especially in immunocompromised age groups
(Steinbach et al. 2012). A. fumigatus also produces the myco-
toxin gliotoxin (GLI) (Kupfahl et al. 2008). Indeed, in
Manchester, UK, azole-resistant strains were first detected in
1999 (Howard et al. 2009) and are now commonly found in
Switzerland, USA, India and China (Hurst et al. 2017;
Lockhart et al. 2011; Riat et al. 2018). However, at the present
time, no regulations exist with regard to GLI exposure.
Streptomyces species are gram-positive filamentous bacte-
ria, which can grow in various ecosystems, including sea
sponges (Han et al. 2009), soil (Nguyen et al. 2015), animal
faeces (Wang et al. 2014) and termites (Zhang et al. 2013).
They are able to produce both secondary metabolites (Wang
et al. 2013; Zhang et al. 2013) and hydrolytic enzymes
(Karthik et al. 2015; Nagpure and Gupta 2013) or potentially
novel anti-microbial compounds (Yang et al. 2015; Yekkour
et al. 2015; Shakeel et al. 2018). Some compounds have been
shown to inhibit spore germination (Wang et al. 2013; Zhang
et al. 2013) and mycelial growth of spoilage fungi (Nguyen
et al. 2015). However, many studies have screened metabo-
lites for efficacy only against mycelial growth with less em-
phasis on control of mycotoxin production or in relation to
different interacting environmental conditions. There have
thus been significant research efforts to screen, isolate and
identify novel compounds with antifungal activities from
Streptomyces strains.
Previously, Sultan and Magan (2011) examined a
Streptomyces strain (AS1) isolated from peanuts. This was
found to be competitive and some extracts from the culture
were found to be very effective at inhibiting Aspergillus flavus
and aflatoxin B1 production, both in vitro and in stored pea-
nuts. However, this Streptomyces strain and its metabolites
have not previously been screened against other spoilage toxi-
genic moulds or indeed against any human fungal disease-
causing pathogens or for control of toxin biosynthesis. In ad-
dition, the compounds responsible for the inhibition were not
previously identified. The objectives of this study were to
determine the efficacy of the Streptomyces AS1 metabolites
on (a) spore germination and mycelial growth of
P. verrucosum, Fusarium verticillioides and A. fumigatus,
(b) efficacy for control of the production of OTA, FUMs and
GLI and (c) to identify the major metabolites produced by the
Streptomyces AS1 strain responsible for the control achieved.
Materials and methods
Bacterial strain
A Streptomyces AS1 strain was obtained from the Applied
Mycology Collection, Cranfield University. This strain was
previously isolated from Egyptian peanuts by Dr. Y. Sultan
(Sultan and Magan 2011). This strain was subsequently iden-
tified as Streptomyces parvus based on molecular analyses
(99%; EU accession number: EU841619.1).
Mycotoxigenic fungal strains
Fusarium verticillioides was from the Applied Mycology
Collection, Cranfield University. It was isolated from maize
by Dr. N.I.P. Samsudin and molecularly identified (Samsudin
et al. 2017) and Penicillium verrucosum (OTA11) and
Aspergillus fumigatus (strain Mi538) were kindly provided
by Dr. M. Olsen (National Food Administration, Uppsala,
Sweden). These fungal strains have all previously been dem-
onstrated to produce high titres of their respective toxins
(Cairns-Fuller et al. 2005; Samsudin et al. 2017).
Preparation of spore suspensions
Streptomyces AS1 and test mycotoxigenic fungi A glycerol
stock solution of Streptomyces AS1 was inoculated on half
nutrient agar (½NA) and incubated at 25 °C for 5 days or until
sporulation had occurred. The colonies were flooded with
sterile 10 ml of 0.1% (w/v) Tween-80/water solution and har-
vested by gently scraping the colony with a sterile spreader to
release the spores and this was then transferred aseptically into
a sterile 50-ml conical tube and the density adjusted to 1.0 at
OD600 or approximate 10
8 spores/ml.
A. fumigatus and F. verticillioides were grown on malt
extract agar (MEA; Oxoid Ltd) and P. verrucosum on potato
dextrose agar (PDA, Oxoid Ltd) for 7 to 10 days or until
sporulation occurred at 25 and 30 °C (A. fumigatus only).
Fungal spores were harvested by pouring 10 ml of sterile
0.1% Tween-80/water solution onto the agar surface
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containing the cells or spores and gently scraping with a
surface-sterilized glass rod. The cell/spore suspensions were
transferred into sterile 50-ml tubes, centrifuge at 2000 rpm for
2 min and the supernatants discarded. Fresh sterile 0.1%
Tween-80/water was added. The concentration of fungal
spores was counted using a haemocytometer (Thoma,
Germany) and adjusted to approx. 106/ml with sterile 0.1%
Tween-80/water solution.
Spore germination assays: media preparation, inoculation
and incubation Molten cooled autoclaved ½NA was poured
into Petri plates (90mm∅) in a sterile flow bench and allowed
to solidify. The cooled media were overlaid with a sheet of
sterile cellophane (8.5 cm diameter) carefully to avoid any air
bubbles. A single colony of Streptomyces AS1 was streak
plated on the ½NA previously overlaid with a sterile cello-
phane sheet and incubated at 25 °C for 10 days. At different
time intervals (days 2, 5 and 10), the cellophane layer with the
StreptomycesAS1 biomass was carefully removed and 100 μl
of spore suspension (106 spores/ml) of the test pathogens was
spread plated onto the agar surface with a sterile glass spread-
er. These Petri plates were then incubated for 48 h.
P. verrucosum and F. verticillioides were incubated at 25 °C
and A. fumigatus treatments at 30 °C. After 24 and 48 h, two
agar plugs (18 mm ∅) were taken randomly and placed on a
glass slide. They were stained with lactophenol cotton blue,
covered with a coverslip prior to microscopic examination. A
total of 50 spores in each of four fields were counted in each
replicate and the number recorded. Spores were considered
germinated when the germ tube length was equal to or greater
than the spore diameter (Magan 1988). The experiments were
all carried out with three replicates per treatment and repeated
once.
Mycelial growth and mycotoxin assays
Preparation of cell-free supernatant for growth and mycotox-
in inhibition assays The Streptomyces AS1 spore suspension
(200 μl) was inoculated into 200 ml ½ strength sterile nutrient
broth (NB) and incubated at 30 °C at 200 rpm for 4 days. After
4 days, the supernatant was separated from the mycelium by
filtration using Whatman filter paper no. 4.
Extraction of Streptomyces AS1 bioactive metabolites using
ethyl acetate Bioactive metabolites from the Streptomyces
AS1 supernatant were extracted three times with ethyl acetate
(EA) (Sultan and Magan 2011). Approx. 900 ml of cell-free
supernatant was mixed with 300 ml of EA in a separating
funnel and after shaking for a few seconds, the mixture was
left to separate into two layers. The EA layer (upper layer)
containing the bioactive metabolites was collected and the
extraction phase was repeated three times. The EA layers con-
taining the bioactive metabolites were combined and the
solvent was removed using a rotary evaporator at 38 °C. The
dried film was dissolved in DMSO under sterile conditions for
performing the assays.
Efficacy of Streptomyces AS1 EA extract
against fungal pathogens using the BioScreen C
turbidimetric assay
Preparation of culture medium The culture medium used to
inoculate the fungal pathogen was prepared as described by
Medina et al. (2012). Water was used to prepare the medium
and this was adjusted with glycerol to 0.99 and 0.95 water
activity (aw). The culture media used were semi-solid YES
(yeast extract sucrose) for P. verrucosum and A. fumigatus
and PD for F. verticillioides. Each culture medium contained
the following: (1) YES: yeast extract 20 g/l, sucrose 150 g/l,
MgSO4.H2O 0.5 g/l and 0.05% agar (w/v) and (2) PD: potato
extract 4 g/l, dextrose 20 g/l and 0.03% agar. Both culture
media were sterilized at 121 °C for 15 min.
Culture medium containing AS1 ethyl acetate extract and
spore suspensions A mixture of 9800 μl culture medium,
100 μl of spore suspensions (final spore count 105 spores/
ml) and 100 μl of EA extract (final concentrations of
5 μg/ml, 10 μg/ml, 20 μg/ml, 30 μg/ml and 40 μg/ml; w/v)
was prepared in sterile 25-ml universal bottles. A total of
300 μl of the mixture were loaded into 100-well microtitre
plates and the density measured automatically at 600 nm every
30 min at 25 °C for 7 days for P. verrucosum and
F. verticillioides and at 37 °C for A. fumigatus. This method
was based on that developed for screening compounds for
efficacy against filamentous fungi using the BioScreen C bio-
assay (Medina et al. 2012). Each set of experiments was car-
ried out with ten replicates. The relative time to reach an ab-
sorbance value of 0.1 (time to detection; TTD-0.1) was then
compared as an indication of growth rates. The raw data was
analysed using Microsoft Excel to obtain the growth curve for
the fungal species. The TTD of 0.1, minimum inhibitory con-
centrations (MIC) and IC50 concentrations were calculated
using the Lambert-Pearson model (Lambert and Pearson
2000).
Agar medium containing EA extract and inoculation
of fungal spores
Approximately 100 μl of the different concentrations of the
EA extract (0–40 μg/ml) was added aseptically into 10 ml
sterile YES (for P. verrucosum and A. fumigatus) and PD
(for F. verticillioides) agar (± 52 °C) with different aw levels
(0.99 and 0.95) and inverted several times before pouring into
Petri plates (53 mm ∅). After the agar media had solidified,
100 μl of spore suspension (107 spores/ml) was spread plated
using a surface-sterilized glass spreader and incubated at
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25 °C for P. verrucosum and F. verticillioides and 37 °C for
A. fumigatus for 7 days. After 7 days, the agar plugs were
collected for mycotoxin analysis.
Extraction and quantification of ochratoxin A,
gliotoxin and fumonisins
Ochratoxin A A total of five agar plugs of P. verrucosum after
7 days growth on YES medium were randomly collected
across the colony using a sterile cork borer (number 5) and
transferred into pre-weighed 2-ml tubes and re-weighed to
obtain the weight of the agar plug. The extraction of ochra-
toxin A (OTA) from the agar plug was carried out using 1 ml
of methanol. The samples were shaken at 200 rpm and 30 °C
in the dark for 1 h. Samples were then centrifuged at 15,000g
for 5 min and the methanol containing OTAwas filtered (ny-
lon syringe filter, 0.22 μm pore size, Fisher) into amber and
silanized HPLC vials (Agilent, UK) for analysis.
The separation and quantification of OTAwas done using
an Agilent 1200 Series HPLC system (Agilent, UK) with a
fluorescence detector. The separation was done at 25 °C using
a Poroshell 120 EC-C18 (4.6 mm× 100 mm, 2.7 μm) column
fitted with a guard column (4 mm × 3 mm cartridge,
P h e n om e n e x , USA ) . T h e mo b i l e p h a s e w a s
water:acetonitrile:acetic acid (41:57:2, v/v/v). The flow rate
and injection volume were 1 ml/min and 20 μl, respectively.
The detection wavelength was 333 nm for excitation and
460 nm for emission. Different concentrations of OTA stan-
dards (0–400 ng/ml) were prepared by dissolving OTA stan-
dard (Sigma) solution in methanol (R2 = 0.9994). The LOD
and LOQ were 12.3 ng/ml and 41.1 ng/ml, respectively.
Gliotoxin The agar plugs of the growing colonies were obtain-
ed as described previously for OTA. The extraction was car-
ried out using chloroform (1 ml) for 1 h at 30 °C and shaken at
200 rpm. After this, 800 μl chloroform containing gliotoxin
(GLI) was transferred into a new 2-ml tube and dried over-
night in a fume cupboard. The dried extract was dissolved in
700 μl of mobile phase solution (1% acetic acid:acetonitrile
(75:25, v/v) and filtered into amber and silanized HPLC vials
for analysis.
The separation and quantification of GLI was done
according to Alonso et al. (2016) with slight modification.
The GLI concentration was measured using a reversed-phase
HPLC system linked to a diode array detector (DAD). The
separation was done at 25 °C using a Zorbax Eclipse XDB-
C18 (4.6 mm× 150 mm, 5.0 μm,Agilent, USA) column fitted
with a guard column (4 mm× 3 mm cartridge, Phenomenex,
USA). The mobile phase was acetic acid:water (1:99, v/v)
(eluent A) and acetonitrile (eluent B). The flow rate, injection
volume and detection wavelength were 1.3 ml/min, 50 μl and
268 nm respectively. The gradient programme was 25% B for
10 min followed by rapid increased to 100% in 1 min and this
was held for 8 min before decreasing this to 25% in 2 min.
Working GLI standard solution with a concentration range
from 0 to 3000 ng/ml was prepared by diluting GLI standard
(Sigma) in mobile phase (R2 = 0.9999). The LOD and LOQ
were 41 ng/ml and 138 ng/ml, respectively.
Fumonisins Fumonisins B1 and B2 (FB1, FB2) are the main
mycotoxins in the suite produced by F. verticillioides. The
agar plugs were extracted by adding 1 ml of acetonitrile:water
(50:50, v/v) and shaking the mixture at 200 rpm for 1 h at
30 °C. Acetonitrile:water (50:50, v/v) containing FB1 and FB2
was then filtered into amber and silanized HPLC vials for
analysis.
The separation and quantification of FBs was done using the
HPLC-FLD system (Agilent, UK). The separation was done
using a Zorbax Eclipse Plus C18 (4.6 mm × 150 mm,
3.5 μm) column + a guard column (security guard, 4 mm×
3 mm cartridge, Phenomenex, USA) at 30 °C. The detection
was at 335 nm for the excitation and 440 nm for the emission
wavelength. The mobile phase was 50 mM NaH2PO4 (pH
4.01):methanol (50:50, v/v) (eluent A) and acetonitrile:water
(80:20) (eluent B). The injection volume was 15 μl with a flow
rate of 1 ml/min. The gradient programme was 0%B for 5 min,
increasing B to 50% in 1 min and held for 7.10 min before
slowly increasing to 80% in 6.90 min. Before injecting the
standards or samples, 10 μl of standards or samples was mixed
with 5 μl of derivatization solution (OPA). The derivatization
solution consisted of 1 ml ortho-phthaldialdehyde (40 mg of
OPA in 1 ml absolute methanol), 5 ml of 0.1 M
Na2B4O7.10H2O and 50 μl of 2-mercaptoethanol. The deriva-
tization was carried out with an auto-derivatization programme
in the HPLC system. Different concentrations of FB standards
(0–5 μg/ml) were prepared by diluting FB standard solution
(Sigma-Aldrich, USA) in acetonitrile:water (50:50, v/v) (R2 =
0.9972 for FB1 and 0.9959 for FB2). The LOD and LOQ were
0.37 μg/ml and 1.21 μg/ml for FB1 and 0.44 μg/ml and
1.48 μg/ml for FB2, respectively.
Identification of bioactive compounds
from Streptomyces AS1 EA extract
Sample preparation, detection and quantification were per-
formed as described by Malachová et al. (2014). Briefly, the
extraction solvent (acetonitrile/water/acetic acid; 79/20/1) was
added to dried ethyl acetate extract and after shaking and
centrifugation, the extract was injected into LC-MS/MS
equipped with a TurboVelectrospray ionization (ESI) source.
The Phenomenex C18-column (150 × 4.6 mm, 5 μm) fitted
with a C18 security guard cartridge (4 × 3 mm) was used to
separate the compounds. The mobile phases consisted of
methanol/water/acetic acid with the ratio of 10/89/1 (v/v/v)
for eluent A and 92/2/1 (v/v/v) for eluent B. Both eluents
contain 5 mM ammonium acetate.
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Dual-culture assays
Single colonies of the StreptomycesAS1 were inoculated onto
½NA as a 2-cm streak approximately 2 cm from the 9-cm
Petri plate edge. After incubation at 25 °C for 48 h, an amount
of 5 μl of fungal spore suspension (106 spores/ml) was applied
at a distance of 3–4 cm from the Streptomyces AS1.
A. fumigatus assays were incubated at 30 °C and the other
assays at 25 °C for 7 days. The inhibition was determined
based on the fungal colony area and macroscopic interaction
between the dual cultures with each colony given an individ-
ual numerical score. These were added up to obtain an overall
index of dominance (ID) as developed by Magan and Lacey
(1984). Each interacting species was given an individual score
based on the following numerical scores: 1:1—mutual
intermingling, 2:2—mutual antagonism on contact, 3:3—mu-
tual antagonism at a distance, 4:0—dominance of one species
on contact and 5:0—dominance of one species over the other
at a distance. All the experiments were done with three tripli-
cates per treatment and repeated once.
Statistical analysis
Normal distribution of data was checked by the Shapiro-
Wilk W test. The general influence of antifungal extract
on fungal growth and mycotoxin production were checked
using one-way analysis of variance (ANOVA) for normal
distribution and the Kruskal-Wallis tests (rank sums) for
non-normally distributed data. Student’s t test was further
applied to compare the means for each treatment for nor-
mally distributed data and the Wilcoxon method (non-
parametric comparison) for non-normal distribution
datasets. A significance level of p < 0.05 was used to
compare treatment. The JMP Pro (SAS Institute Inc.,
Cary, NC, USA) was used for these analyses.
Results
Streptomyces AS1 for control of fungal pathogens
using dual-culture assays
A significant reduction in the colony area (cm2) of all the
toxigenic fungi occurred in the presence of Streptomyces
AS1 culture (Fig. 1). The inhibition was best against
P. verrucosum (90%) followed by A. fumigatus strain
(Mi538; 59%) and F. verticillioides (51%). The interaction
score between the Streptomyces AS1 and the isolates of all
three species was 5:0, indicating dominance at a distance. The
total ID, which was the sum of the individual scores, was thus
15:0 (AS1:mycotoxigenic strain). Indeed, the mycotoxigenic
strains of all three species grew away from the Streptomyces
AS1 strain. There was no increase in the colony area of the
pathogens after day 3, especially for P. verrucosum.
Identification of bioactive compounds
from the Streptomyces AS1 strain
Table 1 shows the major compounds extracted from the ethyl
acetate fraction of the StreptomycesAS1 strain biomass. There
were four major compounds present. These included
valinomycin (150 μg/g dry biomass), cyclo(L-Pro-L-Tyr)
(22 μg/g), cyclo(L-Pro-L-Val) (10 μg/g) and brevianamide F
(3 μg/g). In addition, six very minor compounds common in
some food matrices were identified as rugulusovin,
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Table 1 Mean
concentrations of
compounds isolated
from ethyl acetate extract
of Streptomyces AS1
supernatant. The major
compounds are in italics
Compounds Concentration
(μg/g dried
biomass)
Valinomycin 150
Cyclo(L-Pro-L-Tyr) 22
Cyclo(L-Pro-L-Val) 10
Brevianamide F 3
Rugulusovin 1
Tryptophol > 1
Chloramphenicol > 1
Monactin, dinactin,
nonactin
> 1
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tryptophol, chloramphenicol, monactin, dinactin and nonactin
(all < 0.7 μg/g; Adetunji et al. 2019).
Efficacy of Streptomyces AS1 metabolites for control
of spore germination of P. verrucosum,
F. verticillioides and A. fumigatus (strain Mi538)
Figure 2 shows the efficacy of the mixture of metabolites
secreted by Streptomyces AS1 on the germination of conidia
of P. verrucosum, A. fumigatus (Mi538) and F. verticillioides.
None of the P. verrucosum conidia germinated in all the treat-
ment conditions tested. However, 85% ofA. fumigatus conidia
germinated after 48-h incubation. For F. verticillioides, there
was very little efficacy in controlling microconidial
germination.
Effect of Streptomyces AS1 ethyl acetate extract
on time to detection of P. verrucosum, A. fumigatus
(Mi538) and F. verticillioides using the BioScreen
assay method
Figure 3 shows an example of the mean growth curve of
P. verrucosum and F. verticillioides obtained after inoculation
with different concentrations of Streptomyces AS1 ethyl ace-
tate extract at 0.95 aw levels over 7 days.
Figure 4 shows the effect of different concentrations of the
AS1 ethyl acetate extract at two water activity levels (0.99 and
0.95 aw) on the time to detection (TTD) at an OD equal to 0.1
for P. verrucosum, A. fumigatus and F. verticillioides. Overall,
the TTD of P. verrucosum was the highest at both aw levels,
followed by A. fumigatus and F. verticillioides. For
P. verrucosum, AS1 extract at 5 μg/ml resulted in a significant
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increase (p < 0.05) of the TTD at both aw levels indicative of
effective control of growth. At 0.99 aw, there was a significant
increase in the TTD (p < 0.05) until 30 μg/ml after which the
effect stabilized. For A. fumigatus, with freely available water
(0.99 aw), the TTD was significantly increased until 30 μg/ml
concentration. At 0.95 aw, this was for concentrations up to
20 μg/ml. For F. verticillioides, the TTD was significantly
increased (p < 0.05) with concentrations up to 20 μg/ml of
AS1 extract at both aw levels.
The minimum inhibitory concentration (MIC) and the IC50
concentrations of the AS1 extracts were determined and shown
in Table 2. The MIC for P. verrucosum, A. fumigatus (Mi538)
and F. verticillioides growth at both aw levels was more than the
highest concentration tested (> 40 μg/ml). The IC50 for
P. verrucosum suggested that it was the most sensitive with
0.15 μg/ml and 0.005 ng/ml at 0.99 and 0.95 aw, respectively.
Efficacy of Streptomyces AS1 ethyl acetate extract
on mycotoxin production
The effect of the AS1 extract (Table 3) on mycotoxin produc-
tion was examined. For P. verrucosum, complete control of
OTA production was achieved, regardless of aw level at the
lowest concentration tested (5μg/ml). For gliotoxin, there was
relatively little control by the concentration range tested at
both aw levels. Indeed, there appeared to be some stimulation
at intermediate concentrations. Even at 40μg/ml, there was no
difference between the control and the treatment at both aw
levels. For F. verticillioides, there was a significant reduction
(p < 0.05) in FB1 and FB2 at both aw levels when compared
with the control. AS1 concentrations of 5–40 μg/ml gave sim-
ilar inhibition of FB1 at both aw levels and FB2 at 0.95 aw. For
FB2/0.99 aw, > 20 μg/ml AS1 was needed to significantly
(p < 0.05) inhibit production.
For P. verrucosum, because no OTAwas detected at 5 μg/ml
AS1 extract, further studies with lower concentration of AS1
extract were carried out to identify more accurately the concen-
trations at which complete inhibition of OTA occurred. Figure 5
shows that there was a significant decrease in OTA production at
0.99 and 0.95 aw when the concentration was 1.25 μg/ml and
complete inhibition at ≥ 2.5 μg/ml. However, at very low con-
centrations of 0.15 μg/ml and 0.99 aw, the OTA production was
stimulated when compared with the untreated control.
Discussion
In the present study, the StreptomycesAS1 strain produced com-
pounds which could control the activity of food spoilage
mycotoxigenic fungi and an opportunistic human one. In
colony-based interactions, the Streptomyces AS1 generally
inhibited all three species tested with an interaction score of 5:0
indicating dominance at the distance and the production of anti-
fungal metabolites. Previous studies with Streptomyces species
have been associated with the production of primary and second-
ary metabolites including hydrolytic enzymes and antibiotic-like
compounds (Prapagdee et al. 2008; Taechowisan et al. 2005).
The effect of the mixture of Streptomyces AS1 metabolites
on spore germination of strains of P. verrucosum,
F. verticillioides and A. fumigatus was dependent on the time
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Fig. 4 Effect of Streptomyces AS1 ethyl acetate extract on the time to
detection (TTD; optical density of 0.1 at 600 nm) for a P. verrucosum, b
A. fumigatus and c F. verticillioides. Data are mean of ten replicates with
bars indicating standard deviation. Different letters indicate significant
differences (p < 0.05) within treatments
Table 2 Minimum inhibitory concentration (MIC) and IC50 of the
Streptomyces AS1 ethyl acetate extract for controlling growth of isolates
of P. verrucosum, A. fumigatus strain Mi538 and F. verticillioides
Fungal strain Water activity
(aw)
MIC
(μg/ml)
IC50 (μg/ml)
P. verrucosum 0.99 > 40 0.15
0.95 > 40 0.000005
A. fumigatus (Mi538) 0.99 > 40 > 40
0.95 > 40 10.45
F. verticillioides 0.99 > 40 > 40
0.95 > 40 > 40
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frame of cultivation of the Streptomyces AS1 strain. With lon-
ger culturing times, more metabolites were produced resulting
in better efficacy, especially against P. verrucosum. None of the
spores germinated under all conditions tested. In contrast, the
mixture of compounds was not effective against A. fumigatus
and F. verticillioides although the metabolites did delay germi-
nation. Previously, complete inhibition of conidial germination
of A. flavus spores by metabolites of Streptomyces AS1 has
been reported (Sultan and Magan 2011).
The efficacy of the mixture of the Streptomyces AS1 extract
was further examined using a spectrophotometric turbidimetric
rapid assay method using the BioScreen C system. The effects of
different concentrations of metabolites from the AS1 strain and
water activity (aw) on the TTD for P. verrucosum,
F. verticillioides and A. fumigatus and on mycotoxin production
were studied. The TTD represents the initial growth phase of the
fungi. The shorter the TTD, the less effective the mixture of
metabolites were on fungal growth. Overall, the AS1 mixed
extract was more effective in controlling growth of
P. verrucosum, even at low concentrations. This paralleled the
findings on effects on conidial spore germination inhibition of
the strain of this species. More importantly, the mixed AS1 ex-
tract suppressed production of OTA by P. verrucosum and also
reduced the production of FB1 and FB2 by F. verticillioides at
both aw levels examined. Indeed, OTA was not detected when
5 μg/ml of the the AS1 extract was used. Thus, more detailed
efficacy testing was done to determine the lowest concentrations
which could be used to inhibit OTA production. Complete inhi-
bition of OTA production was achieved at very low concentra-
tions (2.5 μg/ml). Thus, the predominant metabolites produced
by the Streptomyces AS1 were fungistatic against spore germi-
nation and growth of P. verrucosum, and the IC50 concentrations
were < 0.20 μg/ml and resulted in complete inhibition of OTA
mycotoxin production at both aw levels tested. However, this did
not occur with the A. fumigatus, responsible for aspergillosis of
the lungs, where there was no control of gliotoxin production.
Previous studies with other Streptomyces strains have sug-
gested no effect on P. verrucosum growth, only some
Table 3 Efficacy of Streptomyces AS1 ethyl acetate extract for control
of OTA, gliotoxin and fumonisin production by isolates of P. verrucosum,
A. fumigatus strain Mi538 and F. verticillioides, respectively. Data are
means of three replicates with SE. Different letters (capitals, 0.99 aw;
lowercase letters, 0.95 aw) indicate significant differences (p < 0.05)
between treatments by Student’s t method for gliotoxin at 0.95 aw and
the Wilcoxon method (non-parametric comparison) at 0.99 aw. ND none
detected
AS1 concentration
(μg/ml)
Water activity
(aw)
OTA
(μg/g agar)
Gliotoxin
(μg/g agar)
Fumonisins (μg/g agar)
FB1 FB2
0 0.99 10.5 ± 4.9 4.1 ± 0.76A 3.73 ± 0.07A 4.57 ± 0.49A
0.95 13.2 ± 3.1 2.2 ± 0.44cd 0.84 ± 0.01a 0.96 ± 0.15a
5 0.99 ND 6.9 ± 0.30A 0.10 ± 0.002B 4.20 ± 0.15A
0.95 ND 3.8 ± 0.34a 0.06 ± 0.04b 0.18 ± 0.04b
10 0.99 ND 4.1 ± 0.20A 0.09 ± 0.003B 4.70 ± 0.66A
0.95 ND 3.4 ± 0.70ab 0.03 ± 0.01b 0.09 ± 0.02bc
20 0.99 ND 7.0 ± 0.03A 0.07 ± 0.01B 2.26 ± 0.70B
0.95 ND 2.9 ± 0.14bc 0.04 ± 0.002b 0.07 ± 0.01bc
30 0.99 ND 5.0 ± 1.10A 0.06 ± 0.003B 1.42 ± 0.23B
0.95 ND 1.9 ± 0.06d 0.03 ± 0.01b 0.07 ± 0.01c
40 0.99 ND 4.1 ± 0.15A 0.06 ± 0.03B 1.32 ± 0.56B
0.95 ND 2.4 ± 0.50cd 0.03 ± 0.01b 0.08 ± 0.01bc
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Fig. 5 Efficacy of Streptomyces
AS1 ethyl acetate extract for
control of OTA production by
P. verrucosum at 25 °C. Data are
means of triplicates with bars
indicating standard errors.
Different letters indicate
significant differences (p < 0.05)
within treatments. n.d. none
detected
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inhibition of A. fumigatus, but good efficacy against
F. verticillioides (Nguyen et al. 2018; Paškevičius et al.
2014). However, previous studies only focused on control of
mycelial growth and not on mycotoxin production. A
previous study by Medina et al. (2007) found compounds
from another Streptomyces strain were effective in controlling
Aspergillus carbonarius growth and OTA production.
A total of 10 compounds were found to be present in the AS1
ethyl acetate extract. The major compound present was
valinomycin (150 μg/g). Three others present which may have
contributed to the anti-fungal activity were cyclo(L-Pro-L-Tyr),
cyclo(L-Pro-L-Val) and brevianamide F. Comparisonsweremade
between efficacy of the mixed AS1 extract and valinomycin and
cyclo(L-Pro-L-Tyr) alone and as a mixture, for which standards
are available. Thesewere found to have no effect on growth of the
target species when compared with the mixed AS1 metabolites
(MohD Danial 2019). This suggests that the combined mixture
hasmuch better efficacy than themajor individual compound or a
mixture of the two main compounds alone.
The production of these compounds by other Streptomyces
species and bacteria such as Bacillus sp. N strain, Pseudomonas
aurantiaca and Cellulosimicrobium cellulans has been reported
previously (Buedenbender et al. 2018; Gwee Kyo et al. 2011;
Kumar et al. 2013; Li et al. 2006; Park and Shim 2014; Park et al.
2008, Wattana-Amorn et al. 2016). The other compounds found
were mainly cyclic ionophores which were present in very low
amounts and thus probably did not directly contribute to the anti-
fungal activity. Previous studies have shown variable results in
terms of efficacy depending on the target fungal genera or species
including Aspergillus, Fusarium, Penicillium, Rhizoctonia and
Candida species (Gwee Kyo et al. 2011; Kumar et al. 2013;
Park and Shim 2014; Park et al. 2008). Although brevianamide
F was a relatively minor component, its potential role in anti-
fungal activity has not been previously described.
In conclusion, the mixture of metabolites produced by the
Streptomyces AS1 species was more effective in suppressing
spore germination and mycelial growth of P. verrucosum than
of F. verticillioides or A. fumigatus. Avery low concentration
of AS1 extract was able to inhibit mycelial growth of
P. verrucosum by 50% although > 40 μg/ml of the mixture
of compounds was needed for complete inhibition. The mix-
ture of metabolites produced by the Streptomyces AS1 suc-
cessfully inhibited OTA production by P. verrucosum
completely at concentrations of 2.5 μg/ml. The potential for
using the mixture of these metabolites now needs to be exam-
ined in situ in stored temperate cereals to examine the efficacy
for control of colonization by P. verrucosum and OTA con-
tamination during short- and medium-term storage.
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